In the BioHarmony Drug Report Database
Hydroflumethiazide
Saluron (hydroflumethiazide) is a small molecule pharmaceutical. Hydroflumethiazide was first approved as Saluron on 1982-01-01. It is used to treat edema, glomerulonephritis, heart failure, hypertension, and liver cirrhosis amongst others in the USA.
Trade Name
|
Saluron |
|---|---|
Common Name
|
hydroflumethiazide |
ChEMBL ID
|
CHEMBL1763 |
Indication
|
edema, glomerulonephritis, heart failure, hypertension, liver cirrhosis, nephrotic syndrome |
Drug Class
|
Diuretics (thiazide derivatives) |
Image (chem structure or protein)